3g8i: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: '''Unreleased structure''' The entry 3g8i is ON HOLD Authors: Benardeau, A. et al Description: Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of ty... |
No edit summary |
||
| Line 3: | Line 3: | ||
The entry 3g8i is ON HOLD | The entry 3g8i is ON HOLD | ||
Authors: | Authors: Benz, J., Bernardeau, A., Binggeli, A., Blum, D., Boehringer , M., Grether, U., Hilpert, H., Kuhn, B., Maerki, H.P., Meyer, M., Puentener, K., Raab, S., Ruf, A., Schlatter, D., Gsell, B., Stihle, M., Mohr, P. | ||
Description: Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes | Description: Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar 4 14:45:01 2009'' | ||
Revision as of 12:45, 4 March 2009
Unreleased structure
The entry 3g8i is ON HOLD
Authors: Benz, J., Bernardeau, A., Binggeli, A., Blum, D., Boehringer , M., Grether, U., Hilpert, H., Kuhn, B., Maerki, H.P., Meyer, M., Puentener, K., Raab, S., Ruf, A., Schlatter, D., Gsell, B., Stihle, M., Mohr, P.
Description: Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes
Page seeded by OCA on Wed Mar 4 14:45:01 2009
